肺纤维化在沙尔科毒性病的肺纤维化
Huda Asif1, Manuel Ribeiro Neto2, Daniel Culver3
1University of South Florida, FL, USA . hasif@usf.edu.
概括
在5%的患者中,沙丘病可导致肺纤维化,增加死亡率. 早期诊断和使用抗纤维菌剂的治疗可以减缓疾病的进展.
科学领域:
- 肺部病理学 肺部病理学
- 病理学 病理学 病理学
- 放射学 放射学是一门学科.
背景情况:
- 在5%的病例中,沙丘病症可以进展为肺纤维化,显著增加死亡率.
- 组织病理学揭示了纤维化在细粒瘤周围的淋巴炎模式,Th1到Th2的转移和血管生成与纤维化有关.
- 临床表现包括呼吸困难和咳,经常有肺功能测试显示混合呼吸器缺陷和扩散能力下降.
研究的目的:
- 总结一下与沙尔科毒症相关的肺纤维化症的关键方面.
- 突出诊断标记和成像发现.
- 概述当前和新兴的治疗策略.
主要方法:
- 在沙尔科毒症相关的肺纤维化中对组织病理学发现的审查.
- 临床特征和肺功能测试结果的分析.
- 对血清学标记和CT成像特征的评估.
- 用葡萄糖皮质体,类固醇节约剂和抗纤维性疗法对治疗结果的评估.
- 对并发症和移植资格标准的审查.
主要成果:
- 升高的血清标志物 (可溶性互白素2受体,基托里奥酶,KL-6,化学因配体18) 与疾病进展有关.
- 扫描图像显示出特征性纤维化模式,主要在上部和中部肺部区域.
- 并发症包括与类瘤相关的肺高血压 (SAPH) 和慢性肺阿斯伯吉洛症.
- 抗纤维素药物,如皮尔费尼和宁泰达尼布,已证明有效减缓肺功能衰退.
- 肺移植是晚期疾病 (NYHA III或IV类) 的可行的选择.
结论:
- Sarcoidosis 相关的肺纤维化是一种严重的并发症,具有明显的临床,成像和血清学特征.
- 及时诊断和管理,包括抗纤维菌疗法,对于改善结果至关重要.
- 对于符合条件的患者来说,多学科的护理和考虑肺移植是必不可少的.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features
333
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
333
Pulmonary Tuberculosis II
261
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
261
Other Pulmonary Disorders
869
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
869
Pulmonary Hypertension: Classification and Pathogenesis
216
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
216
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


